AMO pledges $1 million to support research in refractive lenticular science
March 18th 2006Advanced Medical Optics (AMO) announced it will pledge $1 million to support independent research/programming in refractive lenticular science sponsored by the American Society of Cataract and Refractive Surgery (ASCRS) Foundation. I. Howard Fine, MD, ASCRS foundation chairman, announced the AMO grant during the opening general session Saturday morning.
Phakic lenses continue to capture interest for refractive correction
March 17th 2006From the late 1990s to the first decade of the 21st century, there has been increasing interest in different kinds of refractive procedures, Jos? Guell, MD, PhD. One option that has been receiving more and more attention is phakic IOLs. He highlighted some of the factors for this during Cornea Day 2006 at the American Society of Cataract and Refractive Surgery meeting.
EyePAC benefit includes evening at Gump's department store
March 17th 2006yePAC held its annual benefit event at Gump's department store Friday evening prior to the American Society of Cataract and Refractive Surgery (ASCRS) and American Society of Ophthalmic Administrators (ASOA) welcome reception at SBC Park.
ASCRS/ASOA attendees get in the swing at SBC Park
March 17th 2006They're annual rites of spring: the joint meeting of the American Society of Cataract and Refractive Surgery (ASCRS) and American Society of Ophthalmic Administrators (ASOA) and a new season of Major League Baseball. On Friday evening, March 17, the events converged as several thousand ASCRS/ASOA delegates attended a welcome reception at SBC Park, home of the San Francisco Giants.
Be prepared: EMRs are here to stay
March 17th 2006Now is the time for practitioners to begin to do their homework on electronic medical records (EMRs) systems. The federal government has a significant mandate with a large budget to standardize and implement their use in clinical practice, said Richard A. Lewis, MD, at Glaucoma Day at the American Society of Cataract and Refractive Surgery meeting.
Tips ease challenges of cataract surgery in small pupils with angle-closure glaucoma
March 17th 2006Cataract surgery in eyes with angle-closure glaucoma can present the need for small pupil management techniques, said Murray Johnstone, MD. Dr. Johnstone reviewed several pearls for handling these challenging cases at Glaucoma Day at the American Society of Cataract and Refractive Surgery meeting.
Ability to predict risk of progression varies along glaucoma continuum
March 17th 2006Significant progress has been made in the ability to predict progression from ocular hypertension to glaucoma, but the same cannot be said for predicting whether patients with detectable disease will progress to severe visual impairment or blindness, said Kuldev Singh, MD, MPH, at Glaucoma Day at the American Society of Cataract and Refractive Surgery meeting.
Future bodes well for advanced surface ablation techniques
March 17th 2006Advanced surface ablation, such as LASEK and Epi-LASIK, defined as an refractive laser technique that does not create a lamellar flap, is the wave of the future, according to Richard Yee, MD. He said that advanced surface ablations are ideal procedures for problem cases, such as those with thin corneas and high myopia and is even better for routine cases. He spoke during Cornea Day 2006 at the American Society of Cataract and Refractive Surgery meeting.
Phakic lenses continue to capture interest for refractive correction
March 17th 2006From the late 1990s to the first decade of the 21st century, there has been increasing interest in different kinds of refractive procedures, Jos? Guell, MD, PhD. One option that has been receiving more and more attention is phakic IOLs. He highlighted some of the factors for this during Cornea Day 2006 at the American Society of Cataract and Refractive Surgery meeting.
Increasing risk factors for ectasia after LASIK
March 17th 2006Knowledge about the risks factors for corneal ectasia is increasing and some of the risk factors may be very subtle. R. Doyle Stulting, MD, PhD, described how he uncovered some of these factors during Cornea Day 2006 at the American Society of Cataract and Refractive Surgery meeting.
SCORE investigators update, expand enrollment criteria
March 15th 2006Madison, WI?Investigators expanded the eligibility criteria of the SCORE study, a multicenter, randomized clinical trial designed to investigate the safety and efficacy of standard care versus intravitreal triamcinolone acetonide (IVTA) injections for the treatment of macular edema associated with central and branch retinal vein occlusion. The broader standards will accommodate a patient population more closely matched to those seen in the practice setting.
Practice carefully considers femtosecond laser purchase
March 15th 2006Minneapolis?The potential for better flaps, improved outcomes, and happier patients are the factors that motivated the surgeons at Minnesota Eye Consultants to join the ranks of others who are performing all-laser LASIK using the femtosecond laser microkeratome (IntraLase) for flap creation, said Richard L. Lindstrom, MD.
Improved OCT could be valuable for retinal disease management
March 15th 2006Chicago?Optical coherence tomography (OCT) is an important imaging technology that allows high-resolution, cross-sectional imaging of microstructures in the eye. Since the technology was first introduced, successive generations have improved considerably.
SCORE investigators update, expand enrollment criteria
March 15th 2006Madison, WI?Investigators expanded the eligibility criteria of the SCORE study, a multicenter, randomized clinical trial designed to investigate the safety and efficacy of standard care versus intravitreal triamcinolone acetonide (IVTA) injections for the treatment of macular edema associated with central and branch retinal vein occlusion. The broader standards will accommodate a patient population more closely matched to those seen in the practice setting.
Researchers investigate link beween bacterium, AMD
March 15th 2006Boston?Researchers at Massachusetts Eye & Ear Infirmary (MEEI), Boston, have discovered more evidence that inflammation plays a role in the pathogenesis of wet age-related macular degeneration (AMD). A team of investigators found Chlamydia pneumoniae, a pathogen capable of inducing chronic infection, in the diseased eye tissue of several patients with wet AMD, and the bacterium was not present in tissue from the eyes of a small group of patients without AMD.
SynergEyes launches interactive Web site
March 15th 2006Carlsbad, CA?SynergEyes Inc. has launched its interactive Web site at www.synergeyes.com. The site offers the ophthalmic industry and the general public the opportunity to obtain product information for the hybrid contact lenses produced by the company. SynergEyes lenses feature a rigid, gas-permeable center and a soft, hydrophilic outer skirt, resulting in a durable hybrid lens for patients seeking crisp, clear vision with the comfort of a soft lens.
Practice carefully considers femtosecond laser purchase
March 15th 2006Minneapolis?The potential for better flaps, improved outcomes, and happier patients are the factors that motivated the surgeons at Minnesota Eye Consultants to join the ranks of others who are performing all-laser LASIK using the femtosecond laser microkeratome (IntraLase) for flap creation, said Richard L. Lindstrom, MD.
Unexplained visual loss requires thorough exam
March 15th 2006Chicago?Patients with unexplained visual loss are often referred to neuro-ophthalmologists to determine if the problem is associated with the optic nerve or visual pathways. Surprisingly, this is not always the problem, reported Karl C. Golnik, MD, MEd, who spoke during the subspecialty neuro-ophthalmology day at the American Academy of Ophthalmology annual meeting.
Many options to treat nystagmus, more in development
March 15th 2006Baltimore?While once there was little to be done for patients with nystagmus, a series of medications has been discovered over the past 25 years that help many individuals with different forms of the condition, and more options are on the horizon, said David Zee, MD, professor of neurology and ophthalmology, the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore.